Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Infusion vs Bolus in TBI
NCT04686344Phase 1Completed
- Sponsor
- Cairo University
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hypertonic saline in traumatic brain injury (TBI) (2 arms), sponsored by Cairo University. Primary endpoint: Optic Nerve Sheath Diameter at 48 hours. Started Dec 2020; status: completed.
02
Drugs
hypertonic saline
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04686344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686344.